Roger Owen Selected Research

Roger Owen Research Topics

Disease

15	Chronic Obstructive Pulmonary Disease (COPD) 05/2012 - 07/2008
9	Multiple Myeloma 11/2022 - 09/2013
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2024 - 05/2006
4	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 05/2006
4	Neoplasms (Cancer) 01/2022 - 10/2017
4	Breast Neoplasms (Breast Cancer) 12/2012 - 05/2002
3	Asthma (Bronchial Asthma) 12/2008 - 12/2007
2	Lymphoma (Lymphomas) 01/2023 - 01/2022
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2009
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Schnitzler Syndrome 01/2020 - 01/2018
2	Dyspnea (Shortness of Breath) 05/2012 - 05/2011
1	VEXAS syndrome 08/2023
1	Frailty 01/2022
1	Atrial Fibrillation 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Diarrhea 01/2022
1	Fever (Fevers) 01/2022
1	Infections 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Hemolytic Anemia 01/2021
1	Skin Diseases (Skin Disease) 01/2020
1	Vasculitis (Vasculitides) 01/2019
1	Disease Progression 03/2018
1	Monoclonal Gammopathy of Undetermined Significance 12/2017
1	Residual Neoplasm 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2010
1	Cough 03/2010
1	Cytopenia 01/2009
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2009
1	Amyloidosis 01/2009
1	Cryoglobulinemia 01/2009
1	Lymphadenopathy 01/2009
1	Acute Promyelocytic Leukemia 01/2004

Drug/Important Bio-Agent (IBA)

17	indacaterolIBA 05/2012 - 12/2007
10	Bronchodilator Agents (Bronchodilators)IBA 05/2012 - 07/2008
6	Immunoglobulin M (IgM)IBA 01/2023 - 05/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 01/2016
4	Bortezomib (Velcade)FDA Link 11/2022 - 01/2016
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2004
3	Formoterol Fumarate (Oxis)FDA Link 05/2012 - 02/2009
3	Salmeterol Xinafoate (Serevent)FDA Link 05/2011 - 09/2010
2	Lenalidomide (CC 5013)FDA Link 11/2022 - 01/2022
2	Melphalan (Alkeran)FDA LinkGeneric 11/2022 - 01/2021
2	ixazomibIBA 01/2022 - 03/2018
2	ibrutinibIBA 01/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2022 - 07/2010
2	carfilzomibIBA 01/2021 - 01/2016
2	Proteasome InhibitorsIBA 01/2021 - 03/2018
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2018
2	Thalidomide (Thalomid)FDA Link 03/2018 - 09/2013
2	Albuterol (Salbutamol)FDA LinkGeneric 07/2011 - 09/2010
2	Tiotropium Bromide (Spiriva)FDA Link 10/2010 - 07/2010
1	romiplostim FDA Link 08/2023
1	isatuximabIBA 11/2022
1	Everolimus FDA Link 01/2022
1	zanubrutinibIBA 01/2022
1	fludarabineIBA 01/2022
1	Bendamustine Hydrochloride FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	CryoglobulinsIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	ParaproteinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 12/2017
1	Immunoglobulin A (IgA)IBA 12/2017
1	Immunomodulating AgentsIBA 10/2017
1	Fluticasone (Cutivate)FDA LinkGeneric 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2008
1	Beclomethasone (Beclometasone)FDA Link 12/2007
1	Codon (Codons)IBA 04/2005
1	Superoxide DismutaseIBA 05/2002

Therapy/Procedure

7	Therapeutics 02/2024 - 01/2009
4	Radiotherapy 12/2012 - 05/2002
3	Dry Powder Inhalers 02/2009 - 12/2007
1	Drug Tapering 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Plasma Exchange 01/2022
1	Plasmapheresis 01/2022
1	Transplantation 01/2022
1	Stem Cell Transplantation 01/2022
1	Premedication 01/2021
1	Salvage Therapy 01/2009
1	Autologous Transplantation 01/2009